[go: up one dir, main page]

NO20070869L - Fremstilling av hydrokloridsalter av tetrazolderivater - Google Patents

Fremstilling av hydrokloridsalter av tetrazolderivater

Info

Publication number
NO20070869L
NO20070869L NO20070869A NO20070869A NO20070869L NO 20070869 L NO20070869 L NO 20070869L NO 20070869 A NO20070869 A NO 20070869A NO 20070869 A NO20070869 A NO 20070869A NO 20070869 L NO20070869 L NO 20070869L
Authority
NO
Norway
Prior art keywords
irbesartan
preparation
anhydrous
hydrochloride salts
tetrazole derivatives
Prior art date
Application number
NO20070869A
Other languages
English (en)
Inventor
Matej Smrkolj
Renata Jakse
Silvo Zupancic
Original Assignee
Krka Tovarna Zdravil Dd Novo M
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SI200400220A external-priority patent/SI21848A/sl
Application filed by Krka Tovarna Zdravil Dd Novo M filed Critical Krka Tovarna Zdravil Dd Novo M
Publication of NO20070869L publication Critical patent/NO20070869L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Den foreliggende oppfinnelse vedrører sesquihydrat hydrokloridsalt av irbesartan og vannfri hydrokloridsalter av irbesartan. Irbesartan anvendt som utgangsmateriale for fremstillingen av de beskrevne hydroklorider av irbesartan kan være i en hvilken som helst form, for eksempel kan det anvendes når det inneholdes i en reaksjonsløsning, i rå form, i et filtrat inneholdende flere løsningsmidler, eller i en vannfri eller en hvilken som helst solvatisert eller hydratisert form, i amorf form eller i en hvilken som helst kjent krystallform eller i en blanding derav.
NO20070869A 2004-07-29 2007-02-15 Fremstilling av hydrokloridsalter av tetrazolderivater NO20070869L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SI200400220A SI21848A (sl) 2004-07-29 2004-07-29 Priprava seskvihidratne hidrokloridne soli tetrazolskega derivata
SI200400292A SI21849A (sl) 2004-07-29 2004-10-22 Priprava hidrokloridnih soli tetrazolskega derivata
PCT/SI2005/000023 WO2006011859A2 (en) 2004-07-29 2005-07-29 Preparation of hydrochloride salts of tetrazole derivative

Publications (1)

Publication Number Publication Date
NO20070869L true NO20070869L (no) 2007-04-19

Family

ID=35786598

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20070869A NO20070869L (no) 2004-07-29 2007-02-15 Fremstilling av hydrokloridsalter av tetrazolderivater

Country Status (7)

Country Link
US (1) US7875641B2 (no)
EP (1) EP1773818B1 (no)
CA (1) CA2575254A1 (no)
EA (1) EA011713B1 (no)
NO (1) NO20070869L (no)
SI (1) SI21849A (no)
WO (1) WO2006011859A2 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI21965A (sl) * 2005-01-05 2006-08-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Priprava tetrazolskega derivata
FR2886642B1 (fr) * 2005-06-06 2008-05-30 Sanofi Aventis Sa Sels alcalino-terreux d'irbesartan et leur preparation
SI1806130T1 (sl) * 2006-01-09 2010-06-30 KRKA@@d@d@@@Novo@mesto Trden farmacevtski sestavek ki obsega irbesartan
CA2654218C (en) * 2006-04-07 2014-07-22 Lek Pharmaceuticals D.D. Process for the preparation of pure irbesartan
EP2194050A1 (en) 2008-12-08 2010-06-09 KRKA, tovarna zdravil, d.d., Novo mesto A new process for the preparation of irbesartan

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT97078B (pt) 1990-03-20 1997-07-31 Sanofi Sa Processo para a preparacao de derivados heterociclicos n-substituidos e de composicoes farmaceuticas que os contem
US5541209A (en) 1994-08-22 1996-07-30 Bristol-Myers Squibb Company Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative
FR2725987B1 (fr) 1994-10-19 1997-01-10 Sanofi Sa Procede pour la preparation d'un derive de tetrazole sous deux formes cristallines et nouvelle forme cristalline de ce derive
FR2780403B3 (fr) 1998-06-24 2000-07-21 Sanofi Sa Nouvelle forme de l'irbesartan, procedes pour obtenir ladite forme et compositions pharmaceutiques en contenant
CA2469656A1 (en) 2001-12-10 2003-06-19 Dr. Reddy's Laboratories Limited Amorphous form of 2-n-butyl-3-( (2-(1h-tetrazol-5-yl) (1,1'-biphenyl)-4-yl) methyl) -1,3-diazaspiro (4,4') non-1-en-4-one

Also Published As

Publication number Publication date
US20080306128A1 (en) 2008-12-11
US7875641B2 (en) 2011-01-25
CA2575254A1 (en) 2006-02-02
EP1773818A2 (en) 2007-04-18
EA200700198A1 (ru) 2007-06-29
EP1773818B1 (en) 2014-09-24
EA011713B1 (ru) 2009-04-28
WO2006011859A3 (en) 2006-07-06
WO2006011859A2 (en) 2006-02-02
SI21849A (sl) 2006-02-28

Similar Documents

Publication Publication Date Title
NO20050741L (no) Ny fremgangsmate for syntesen og ny krystallinsk form av agomelatin og farmasoytiske sammensetninger inneholdende den
NO20063470L (no) Tetrazolforbindelser og deres anvendelse av metabotrofe glutamatreseptorantagonister
EA200970149A1 (ru) Производные n-(аминогетероарил)-1h-индол-2-карбоксамидов, их получение и их применение в терапии
NO20090628L (no) Pyridizinon derivativater
TW200617009A (en) Organic compounds
NO20092412L (no) Hydantoinderivater anvendes som MMP-inhibitorer
EA200901609A1 (ru) Амиды пиразолкарбоновой кислоты, применимые в качестве микробиоцидов
WO2006134317A8 (en) Oxadiazole derivatives as dgat inhibitors
NO20073720L (no) Heterocyklisk substituerte fenylmetanoner som inhibitorer av glycintransportorer
NO20073663L (no) Tiazol-4-karboksamid-derivater som mGluR5 antagonister
NO20063748L (no) Kinolinderivater og anvendelse derav som mykobakterielle inhibitorer
NO20076145L (no) Ureadeviater, fremgangsmater for deres fremstilling og anvendelse derav
NO20065733L (no) Naftalinderivater nyttige som histamin-3-reseptor ligander
DE602008001725D1 (de) 1-(1-benzylpiperidin-4-yl)benzimidazol-5-carbonsäurederivate zur behandlung von diabetes mellitus
NO20070869L (no) Fremstilling av hydrokloridsalter av tetrazolderivater
WO2004100865A3 (en) New benzimidazole derivatives
NO20083708L (no) 4-Fenyl-tiazol-5-karboksylsyre og 4-fenyl-tiazol-5-karboksylmider som PLK1-inhibitorer
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav
NO20082116L (no) Kjemisk fremgangsmate for fremstilling av en amido-fenoksybenzosyreforbindelse
TW200635921A (en) Organic compounds
TW200512201A (en) New heterocyclic amides
ATE423105T1 (de) Triazolonderivate als mmp-inhibitoren zur behandlung von asthma und copd
NO20084301L (no) Tetrahydronaftalenderivater, fremgangsmate for deres fremstilling og anvendelse derav som anti-inflammatoriske midler
NO20070550L (no) Fremgangsmate for fremstilling av pyrrolotriazinforbindelser
SE0403085D0 (sv) Novel componds

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application